glp 1r retatrutide Research Guide: What the Phase 2 Trial Data Reported (2026) Targeting GLP-1, GIP & GCG

Maybe you simply want a different day

Summary Preclinical rodent model studies indicate that ghrelin signaling promotes conditioned appetitive behaviors and eating in response to food-associated cues, possibly by contributing to an interoceptive state analogous to fasting, by signaling meal anticipation, and/or by increasing the palatability of food

High-fat diet-induced hyperglycemia and obesity in mice: Differential effects of dietary oils

The injection of rAAV-lep increases hypothalamic leptin expression and moderates diet-induced hyperglycemia, hyperinsulinemia, and skeletal muscle insulin resistance (Buettner et al., The therapeutic effects of central leptin gene therapy have been reported in insulin-deficient diabetes and in obesity animal models, such as ob/ob, diet-induced obese mice, insulin-deficient type 1 diabetes mice, and insulin-dependent diabetes animals (Akita mice) (Dube et al., 2004, 2006

GIP may enhance weight loss by directly targeting its receptor in the central nervous system to regulate appetite, enhancing GLP-1s anorectic action, and reducing drug-induced nausea in order to improve the tolerability of and compliance to GLP-1 receptor agonists [45]

Bertoia, M.L., Mukamal, K.J., Cahill, L.E., Hou, T., Ludwig, D.S., et al